Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
about
Implication of inflammatory signaling pathways in obesity-induced insulin resistancePutative role of adipose tissue in growth and metabolism of colon cancer cells.ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype.Tumor progression locus 2 (Tpl2) deficiency does not protect against obesity-induced metabolic diseaseDeletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity.MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.Genetic and pharmacologic inhibition of Tpl2 kinase is protective in a mouse model of ventilator-induced lung injury.A comparison of inflammatory and oxidative stress markers in adipose tissue from weight-matched obese male and female mice.Deficiency of myotubularin-related protein 14 influences body weight, metabolism, and inflammation in an age-dependent manner.Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women.Deletion of tumor progression locus 2 attenuates alcohol-induced hepatic inflammation.Anti-inflammatory and anti-diabetic effects of brown seaweeds in high-fat diet-induced obese miceImpaired mitochondrial metabolism and mammary carcinogenesis'Metabolically healthy obesity': origins and implications.IκB kinase regulation of the TPL-2/ERK MAPK pathway.Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update.Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.Diet-induced hyperinsulinemia accelerates growth of androgen-independent PC-3 cells in vitro.The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.Tumor progression locus 2 ablation suppressed hepatocellular carcinoma development by inhibiting hepatic inflammation and steatosis in miceA role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.Mice lacking myotubularin-related protein 14 show accelerated high-fat diet-induced lipid accumulation and inflammation.[Implication of MAP kinases in obesity-induced inflammation and insulin resistance].TPL2 is a key regulator of intestinal inflammation in C. difficile infection.
P2860
Q27500365-BB2A5088-33B9-47F6-8EA1-7448AEDBEE58Q33808873-FA73EE93-1D26-43B8-9FAB-6144183B9F39Q33836018-C504DA84-5674-458B-A298-285420EA8948Q34305887-D541B191-A275-4B93-A53D-083041267B9BQ34816377-2CF75D8C-3F0B-474C-8D4D-5B20BC80BC00Q35107734-5B82A3F8-AB27-4D89-8A16-93DA91743CC2Q35883560-A9DB4131-D7F3-4484-B6A3-C0BB38F5D62CQ36063497-D56ACC91-CDCA-436C-92A6-F8ADF749AC36Q36393696-6C4FA3F9-6F11-4FB9-A966-50B81F0A69FAQ36510756-632C5B95-9783-4B6D-8C4F-109E67DFCC3BQ36540069-6A8A32F9-7893-4F84-BF16-1BBB96471C4DQ36547060-83ADE7BE-9F11-4E22-97F4-61867E22F1FFQ36636779-28757C93-311E-4BDE-9A2B-149B7AF4BD03Q36641503-8D1C2361-B96E-4323-87F1-502D38265F31Q37995683-C8BF3765-2467-4360-B4A8-F58C80BE46AFQ38005668-93BD682D-1493-415A-8B81-1016C3F1BF6FQ38965219-8928A6C4-FF93-459F-92AD-63B43CCD6F43Q39428124-72C51CF2-75FD-48A5-9F18-C82838AB4F68Q40893687-E02525FD-D872-43CE-A0DB-19F71138F273Q42559592-2957560A-677F-429D-A533-C9375E195598Q49339905-2840ECCB-5049-4BDD-A5E7-485E83046850Q51347911-DC08D808-3483-4154-A498-554E649AE2B7Q54324876-4FB10FC7-664A-4F18-982B-000CC5E7FAA2Q54977805-C04E8B52-7A39-4A93-A883-E7255A8CE1FF
P2860
Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@ast
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@en
Tumor progression locus 2
@nl
type
label
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@ast
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@en
Tumor progression locus 2
@nl
prefLabel
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@ast
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@en
Tumor progression locus 2
@nl
P2093
P2860
P50
P356
P1433
P1476
Tumor progression locus 2 (TPL ...... mation and insulin resistance.
@en
P2093
Andrew S Greenberg
Eugene Chang
James W Perfield
Martin S Obin
Phillip N Tsichlis
Varman T Samuel
P2860
P304
P356
10.2337/DB10-0715
P407
P577
2011-02-23T00:00:00Z